| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443732 | European Journal of Cancer | 2014 | 10 Pages |
Abstract
Our observations indicate that high RBM3 expression is an independent prognostic marker in prostate cancer. The tight link to ERG activation and PTEN deletions suggest interaction with key molecular pathways in prostate cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katharina Grupp, Julia Wilking, Kristina Prien, Claudia Hube-Magg, Hüseyin Sirma, Ronald Simon, Stefan Steurer, Lars Budäus, Alexander Haese, Jakob Izbicki, Guido Sauter, Sarah Minner, Thorsten Schlomm, Maria Christina Tsourlakis,